Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.
暂无分享,去创建一个
Jie Chen | J. Long | Xianjun Yu | Chen Liu | Jin Xu | Q. Ni | G. Luo | He Cheng | K. Jin | Yu Lu | M. Guo
[1] Zuqiang Liu,et al. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[2] Sheng-guang Yuan,et al. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. , 2015, World journal of gastroenterology.
[3] T. Mukhtar,et al. Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group , 2015, Annals of Surgical Oncology.
[4] Zuqiang Liu,et al. Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy , 2014, Annals of Surgical Oncology.
[5] D. Bentrem,et al. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. , 2014, Surgery.
[6] S. Boorjian,et al. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy. , 2014, Urologic oncology.
[7] D. Santini,et al. WHO 2010 classification of pancreatic endocrine tumors. is the new always better than the old? , 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[8] C. Landry,et al. Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors. , 2014, Gland surgery.
[9] J. Ahmad,et al. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. , 2014, Hepatobiliary & pancreatic diseases international : HBPD INT.
[10] Dan Huang,et al. (18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors. , 2014, International journal of oncology.
[11] T. O'Dorisio,et al. Pancreastatin Predicts Survival in Neuroendocrine Tumors , 2014, Annals of Surgical Oncology.
[12] D. Morris,et al. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. , 2014, Surgical oncology.
[13] W. Willinek,et al. Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[14] S. Clarke,et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. , 2013, Critical reviews in oncology/hematology.
[15] P. Kornprat,et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer , 2013, British Journal of Cancer.
[16] N. Malats,et al. Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[17] J. Scoazec,et al. Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours? , 2012, European journal of cancer.
[18] Fenghua Wang,et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer , 2012, Medical Oncology.
[19] Feng Yang,et al. Preoperative diagnosis of nonfunctioning pancreatic neuroendocrine tumors , 2011, Medical oncology.
[20] B. Wiedenmann,et al. From Targets to Treatments: A Review of Molecular Targets in Pancreatic Neuroendocrine Tumors , 2011, Neuroendocrinology.
[21] A. Haynes,et al. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. , 2011, Archives of surgery.
[22] R. Hall,et al. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. , 2010, American journal of surgery.
[23] Manal M. Hassan,et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] K. Conlon,et al. Pancreatic neuroendocrine tumours. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[25] B. Eriksson,et al. Endocrine tumours of the pancreas. , 2005, Best practice & research. Clinical gastroenterology.
[26] D. Klimstra,et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] E. Seregni,et al. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.